Recent News

• 06.11.2025 - James Molloy
• 06.11.2025 - James Molloy
• 06.06.2025 - Notice of Annual General Meeting of Shareholders (AGM) to be held on June 30, 2025
• 05.29.2025 - LIVE! with Webull Corporate Connect
• 05.29.2025 - Akari Therapeutics Releases “Meet the Team” Video Featuring Recently Appointed Mark F. Kubik, Head of Business Development – Oncology
• 05.29.2025 - Akari Therapeutics Releases “Meet the Team” Video Featuring Recently Appointed Mark F. Kubik, Head of Business Development – Oncology
• 05.29.2025 - Akari Therapeutics Releases “Meet the Team” Video Featuring Recently Appointed Mark F. Kubik, Head of Business Development – Oncology
• 05.29.2025 - Akari Therapeutics Releases “Meet the Team” Video Featuring Recently Appointed Mark F. Kubik, Head of Business Development – Oncology
• 05.22.2025 - Akari Therapeutics to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
• 05.22.2025 - Akari Therapeutics to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar

Recent Filings

• 06.06.2025 - ARS Annual Report to Security Holders
• 06.06.2025 - DEF 14A Other definitive proxy statements
• 05.23.2025 - PRE 14A Other preliminary proxy statements
• 05.15.2025 - EX-99.1 EX-99.1
• 05.15.2025 - 8-K Current report